Johnson & Johnson has expanded its consumer health product offering in the UK by securing the Rx-to-OTC switch of its Sudafed Plus Blocked Nose nasal spray.
UK Product Approvals: J&J Expands Sudafed And Nicorette Offerings
The UK's MHRA has approved the Rx-to-OTC switch of J&J's Sudafed Plus nasal spray (xylometazoline hydrochloride/dexpanthenol) and given the green light for the company to add new pack sizes to its Nicorette QuickMist and QuickMist Smart Track products.
